Hetero Healthcare Ltd
↗Hyderabad, India
Hetero Healthcare Ltd is a prominent Indian pharmaceutical company and a key marketing and distribution arm of the Hetero Group. Founded in 2006, the company specializes in branded generic medicines across a wide range of therapeutic areas, including HIV/AIDS, oncology, cardiovascular, neurology, and immunology. It is a global leader in the production of anti-retroviral (ARV) drugs, supplying approximately 40% of the world's HIV/AIDS treatment demand.
The company operates with a vertically integrated business model, leveraging the research and manufacturing capabilities of the broader Hetero Group, which includes over 36 state-of-the-art manufacturing facilities worldwide. Hetero Healthcare is particularly recognized for its rapid response during global health crises, having launched generic versions of Remdesivir (Covifor) and Favipiravir (Favivir) during the COVID-19 pandemic. It also maintains a strong focus on biosimilars through its dedicated arm, Hetero Biopharma.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$141M (Hetero Healthcare Ltd) / $2B-$3B (Hetero Group)
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Multiple Biosimilars & Generics)
Modalities:Small molecule, mAb, Biosimilars, Injectables
Active Trials:15
Trial Phases:Phase 1: 2 | Phase 2: 3 | Phase 3: 10
FDA Approvals:300
EMA Approvals:50
CORPORATE STRUCTURE
Parent Company:Hetero Group
Subsidiaries:Hetero Labs Limited, Hetero Biopharma Limited, Camber Pharmaceuticals (USA), Amarox Pharma (Europe), Annora Pharma, Genx Laboratories
Key Partnerships:Gilead Sciences (Remdesivir licensing), MSD (Molnupiravir licensing), Medicines Patent Pool (MPP) (COVID-19 and HIV drugs), MS Pharma Group (MENA region biosimilars localization), Russian Direct Investment Fund (Sputnik V manufacturing)
COMPETITION
Position:Leader
Competitors:Dr. Reddy's Laboratories, Intas Pharmaceuticals, Lupin Limited, Macleods Pharmaceuticals, Abbott India, Sun Pharmaceutical Industries
LEADERSHIP
Key Executives:
Dr. B. Parthasaradhi Reddy - Chairman
M. Srinivas Reddy - Managing Director
Dr. Vamsi Krishna Bandi - Managing Director, Hetero Group
Scientific Founders:Dr. B. Parthasaradhi Reddy (Founder)
Board Members:Bandi Vamsikrishna, Kalavathi Bandi, Bose Namburi, Srinivas Reddy Male, Santosh Babu Busani
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hetero Healthcare Ltd. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.